PDA has published a companion volume, the PDA Technical Series: Endotoxin Analysis and Risk Management , which collects relevant articles from the PDA Journal of Pharmaceutical Science and Technology that informed TR 82’s development.

. The drug's own formulation—specifically a mix of surfactants and chelating agents—was physically wrapping around the endotoxin, hiding it from detection. This meant a contaminated drug might pass safety tests because the toxins were effectively "cloaked." The Birth of TR 82

Demasking involves adding specific reagents to break down the surfactant-chelator complex, thereby liberating the endotoxin so it can react with the LAL enzyme. Common demasking agents include: Bovine Serum Albumin (BSA) to bind surfactants. Divalent cations (e.g., Mg2+cap M g raised to the 2 plus power Ca2+cap C a raised to the 2 plus power ) to neutralize chelators. Specific diluents that alter the sample matrix physics. Alternative Endotoxin Detection Methods

PDA Technical Report No. 82 was published in March 2019 as a 128-page PDF document with ISBN 9781945584077. As of this writing, PDA has announced a revision team is being assembled to update the document, ensuring its continued relevance as science and regulations evolve.

: Polysorbates and other non-ionic surfactants insert between LPS molecules, forming mixed micelles that mask biologically active sites